Franziska Lademann

6PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Dental therapeutics, pharmacology and toxicologyProsthetics and orthoticsImmunogenetics (incl. genetic immunology)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 07, 2026
Thra knockout protects male mice from hyperthyroidism-driven cortical bone loss by mitigating bone resorption.

Franziska Brinkmann, Eleonore Kreß, Christiane Schirm

|May 08, 2024
Hyperthyroidism-driven bone loss depends on BMP receptor Bmpr1a expression in osteoblasts.

Franziska Lademann, Eddy Rijntjes, Josef Köhrle

|Nov 22, 2023
Thyroid hormone receptor Thra and Thrb knockout differentially affects osteoblast biology and thyroid hormone responsiveness in vitro.

Franziska Lademann, Elena Tsourdi, Lorenz C Hofbauer

|Nov 26, 2022
Irisin and Bone in Sickness and in Health: A Narrative Review of the Literature.

Elena Tsourdi, Athanasios D Anastasilakis, Lorenz C Hofbauer

|Sep 23, 2022
Low Bone Turnover Due to Hypothyroidism or Anti-Resorptive Treatment Does Not Affect Whole-Body Glucose Homeostasis in Male Mice.

Franziska Lademann, Martina Rauner, Nicolas Bonnet

|Oct 20, 2021
The Thyroid Hormone Transporter MCT10 Is a Novel Regulator of Trabecular Bone Mass and Bone Turnover in Male Mice.

Franziska Lademann, Steffen Mayerl, Elena Tsourdi

Pageof 1